2 Gaucher's disease: molecular, genetic and enzymological aspects
- 1 December 1997
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 10 (4) , 635-656
- https://doi.org/10.1016/s0950-3536(97)80032-7
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Saposin C induces pH‐dependent destabilization and fusion of phosphatidylserine‐containing vesiclesPublished by Wiley ,2001
- Function of saposin C in the reconstitution of glucosylceramidase by phosphatidylserine liposomesFEBS Letters, 1993
- Human acid β-glucosidase: use of sphingosyl and N-alkyl-glucosylamine inhibitors to investigate the properties of the active siteBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidosesEuropean Journal of Pediatrics, 1989
- Structural Analysis of the Human Glucocerebrosidase GenesDNA, 1988
- EfficientIn VitroandIn VivoExpression of Human Glucocerebrosidase cDNADNA, 1987
- A Mutation in the Human Glucocerebrosidase Gene in Neuronopathic Gaucher's DiseaseNew England Journal of Medicine, 1987
- The cohydrolases in human spleen that stimulate glucosyl ceramide β-glucosidaseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1983
- Partial Enzyme Deficiencies: Residual Activities and the Development of Neurological DisordersDevelopmental Neuroscience, 1983
- Mechanism of activation of glucocerebrosidase by CO-β-glucosidase (glucosidase activator protein)Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981